VCEL News and Press, Vericel Corporation From 05/04/22

Vericel press release (NASDAQ:VCEL): Q1 GAAP EPS of -$0.15 misses by $0.03. Revenue of $36.07M (+4.3% Y/Y) beats by $1.76M. The company reaffirmed financial guidance for FY2022: Total net revenue in the range of $178M to $189M vs. consensus of $183.62M; MACI revenue expected to be in the...

First Quarter Total Net Revenue of $36.1 Million Conference Call Today at 8:30am Eastern Time CAMBRIDGE, Mass., May 04, 2022 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today re...

Vericel (NASDAQ:VCEL) is scheduled to announce Q1 earnings results on Wednesday, May 4th, before market open. The consensus EPS Estimate is -$0.12 (-71.4% Y/Y) and the consensus Revenue Estimate is $34.31M (-0.8% Y/Y). Over the last 2 years, VCEL has beaten EPS estimates 75% of the time and h...

CAMBRIDGE, Mass., April 20, 2022 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced the following webcast and conference call to discuss its first-quarter 2022 financial results and busi...

The NexoBrid complete response letter sparked a market overreaction on Vericel Corporation stocks. Coupled with the 2021/2022 Biotech Bear market, Vericel shares are trading at a deep bargain to their intrinsic value. Maci continues to generate increasing revenue year-over-year. T...

Vericel is a high growth, disruptive medical technology company with average 5-year sales growth of 24%. The Company’s tissue repair and restoration products are proprietary and backed by medical research showing greater effectiveness than traditional competing solutions/approa...

CAMBRIDGE, Mass., March 15, 2022 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that Nick Colangelo, President and CEO, will present at the Canaccord Genuity Musculoskeletal Conferen...

CAMBRIDGE, Mass., March 01, 2022 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that Nick Colangelo, President and CEO, will participate in a fireside chat at the Cowen 42 nd Ann...

Image source: The Motley Fool. Vericel (NASDAQ: VCEL) Q4 2021 Earnings Call Feb 24, 2022 , 8:30 a.m. ET Operator Continue reading For further details see: Vericel (VCEL) Q4 2021 Earnings Call Transcript

CAMBRIDGE, Mass., Feb. 24, 2022 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that the Board of Directors has appointed Jonathan Siegal as the Company’s Principal Accounting ...